A Study of DS-9606a in Patients With Advanced Solid Tumors

A Study of DS-9606a in Patients With Advanced Solid Tumors
Conditions:   Advanced Cancer;   Metastatic Cancer;   Ovarian Cancer;   Germ Cell Tumor
Intervention:   Drug: DS-9606a
Sponsor:   Daiichi Sankyo, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 4, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments